Skip to Content

Invesco S&P SmallCap Health Care ETF (PSCH US)

PSCH US$55.05

20 minute delayed

Today ▲ 0.54%
1 year return ▲ 28.88%
Volume 1,091
Div yield —
PE ratio —
52 week range
39.13 56.35

14 days free access

Join Market Matters and get full access to all our Opinion + Action

Learn more

Performance

Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.

Share price activity

Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
Last (Price)
55.05
Change
▲ 0.30 (0.54)
Bid / Ask
47.38 - 62.95
Volume
1,091
Turnover
48,914
Open
55.01
Day Range
54.97 - 55.05
VWAP
55.02
Prev Close
54.75
Last Trade
28/10 4:00pm

Fund profile

Displays who issues the fund, how it is structured and invests, its Morningstar category and benchmark, size, headline costs and dates, sourced from Morningstar. Fund size counts every class of the fund; ETF net assets is this listing alone.

Fund size

$173.8M

OCT 2026

Distributions

Quarterly

Since inception

16.6 yrs

APR 2010

Legal name
Invesco S&P SmallCap Health Care ETF
Issuer
Invesco
Type
Exchange-Traded Fund
Structure
Open Ended Investment Company
Management style
Index fund
Morningstar category
Health
Category index
Morningstar US Health TR USD
Benchmark
S&P Composite 1500 TR USD
ETF net assets
$173.8M
Units on issue
3.2M
Management fee
0.29% p.a.
Domicile
United States
Base currency
USD
Inception
7 APR 2010
Listed
7 APR 2010

Objective and strategy

The investment seeks to track the investment results (before fees and expenses) of the S&P SmallCap 600® Capped Health Care Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard.

Asset allocation

Displays how the fund is split between shares, bonds, cash and other assets, sourced from Morningstar.

US equity 99.99%Non-US equity 0.01%

Asset class Net % Long % Short %
Equity 99.99 99.99 —
Bond 0.00 0.00 —
Cash 0.01 0.01 —
Other 0.00 0.00 —

Sector exposure

Displays the share of the fund held in each sector, sourced from Morningstar.

Cyclical 1.35%Sensitive 0.00%Defensive 98.64%

Basic Materials
0.00%
Consumer Cyclical
0.00%
Financial Services
1.35%
Real Estate
0.00%
Communication Services
0.00%
Energy
0.00%
Industrials
0.00%
Technology
0.00%
Consumer Defensive
0.00%
Healthcare
98.64%
Utilities
0.00%

Region exposure

Displays the share of the fund held in each region, sourced from Morningstar.

Developed markets 99.99%Emerging markets 0.00%

North America
99.99%
Latin America
0.00%
United Kingdom
0.00%
Europe Developed
0.00%
Europe Emerging
0.00%
Africa / Middle East
0.00%
Japan
0.00%
Australasia
0.00%
Asia Developed
0.00%
Asia Emerging
0.00%

Country exposure

Displays the twelve countries the fund holds most of, sourced from Morningstar.
United States
99.99%

Style box

Displays where the fund's shareholdings sit on Morningstar's style box: size (large, mid, small) down and investment style (value, blend, growth) across, sourced from Morningstar.
Style
Small Growth

Size score

-3

Small Mid Large

Value-growth score

205

Value Blend Growth

Economic moat

Wide 0%Narrow 37%None 63%

Market capitalisation

Displays the share of the fund's shareholdings in giant, large, mid, small and micro cap companies, sourced from Morningstar.
Giant
0.00%
Large
0.00%
Mid
0.00%
Small
47.09%
Micro
52.90%

Small 47%Micro 53%

Average market cap
$3.54B
Number of holdings
73
Shares held
69

Portfolio statistics · 23 OCT 2026

Displays the valuation, yield, size, concentration and quality of the fund's shareholdings taken together (trailing twelve months), sourced from Morningstar.
Price / earnings
25.23
Price / book
2.80
Price / sales
2.00
Price / cash flow
14.32
Dividend yield
0.21%
Assets in top 10
34.90%
Return on equity
8.06%
Net margin
6.27%

Top holdings · top 10 = 34.91% of assets

Displays the fund's ten largest holdings and their weight in the portfolio, sourced from Morningstar.
Holding % Weight First bought Market value Currency Units held Sector Country
Glaukos Corp GKOS 5.22 MAR 2020 9.3M USD 56,769 Healthcare United States
Protagonist Therapeutics Inc PTGX 4.91 JUL 2024 8.8M USD 62,279 Healthcare United States
TG Therapeutics Inc TGTX 4.26 SEP 2024 7.6M USD 136,506 Healthcare United States
Alkermes PLC ALKS 3.66 DEC 2023 6.5M USD 161,430 Healthcare United States
Ligand Pharmaceuticals Inc LGND 3.36 SEP 2021 6.0M USD 19,183 Healthcare United States
PTC Therapeutics Inc PTCT 2.91 NOV 2025 5.2M USD 80,293 Healthcare United States
Teleflex Inc TFX 2.85 MAR 2025 5.1M USD 40,762 Healthcare United States
Merit Medical Systems Inc MMSI 2.77 APR 2010 5.0M USD 57,442 Healthcare United States
RadNet Inc RDNT 2.63 NOV 2019 4.7M USD 68,136 Healthcare United States
Integer Holdings Corp ITGR 2.31 APR 2010 4.1M USD 32,699 Healthcare United States

Trailing returns · 30 SEP 2026

Displays total returns after fees at net asset value, the return at the ASX market price, the return before fees, and where the fund ranks among funds in its Morningstar category, sourced from Morningstar.

Fund (NAV) Market price

1M

-4.6

3M

-0.7

6M

26.3

YTD

18.0

1Y

25.0

3Y

11.6

5Y

-3.0

10Y

7.8

Period Fund (NAV) % Market price % Before fees % Rank in category
1 month -4.64 -4.65 -4.61 83 / 176
3 months -0.67 -0.57 -0.60 75 / 175
6 months 26.31 26.55 26.49 18 / 171
Year to date 18.03 18.19 18.29 33 / 171
1 year 25.04 25.16 25.40 49 / 170
3 years p.a. 11.58 11.64 11.90 66 / 160
5 years p.a. -3.00 -3.00 -2.72 90 / 153
10 years p.a. 7.78 7.80 8.10 90 / 121

Returns to 30 SEP 2026, periods of 3 years and longer annualised. Rank is the percentile in the Morningstar category at 30 SEP 2026 (1 = best) over the funds ranked.

Calendar year returns

Displays the total return after fees and the capital (price) return for each calendar year, with the fund's rank in its Morningstar category, sourced from Morningstar.

Total Capital

2016

1.9

2017

34.4

2018

9.7

2019

19.9

2020

31.1

2021

5.6

2022

-26.3

2023

-2.6

2024

3.7

2025

-0.5

Year Total % Capital % Rank in category
2025 -0.50 -0.54 97 / 172
2024 3.75 3.47 29 / 176
2023 -2.62 -2.63 85 / 176
2022 -26.32 -26.32 81 / 176
2021 5.62 5.62 63 / 166
2020 31.14 31.14 26 / 157
2019 19.91 19.91 78 / 145
2018 9.69 9.69 7 / 140
2017 34.43 34.43 15 / 144
2016 1.95 1.92 4 / 134
2015 20.29 20.29 1 / 128

Risk statistics · 30 SEP 2026

Displays how the fund has moved relative to its category index: alpha (return beyond the index), beta (sensitivity to it), R-squared (how much the index explains), volatility and risk-adjusted returns, sourced from Morningstar.
1 year 3 years 5 years 10 years
Alpha 14.51 -5.43 -12.13 -3.17
Beta 0.49 0.88 0.89 1.01
R-squared 10.57 24.45 39.98 48.82
Standard deviation 21.40 21.33 21.01 21.24
Sharpe ratio 0.97 0.40 -0.23 0.34
Sortino ratio 2.39 0.74 -0.33 0.52
Tracking error 21.50 18.60 16.31 15.24
Information ratio 0.39 -0.55 -0.89 -0.30
Upside capture % 38.55 66.26 58.80 89.18
Downside capture % -138.63 92.37 117.55 108.95
Maximum drawdown % -9.94 -20.06 -41.27 -44.60

Measured against MSCI ACWI NR USD with USTREAS T-Bill Auction Ave 3 Mon as the risk-free rate, to 30 SEP 2026. Maximum drawdown is on gross returns at the latest quarter end.

Portfolio risk score

Displays Morningstar's Portfolio Risk Score for the fund's holdings, how closely the ETF tracks its index day to day, the estimated cost of holding it against the index, the cost of trading it at market size, and its best and worst quarters since inception, sourced from Morningstar.

Risk score

91.8

Cash 0
Global shares 100

Morningstar Portfolio Risk Score at 30 SEP 2026.

Market impact cost %
0.020
Best quarter
35.12% · JAN 2021
Worst quarter
-23.07% · DEC 2018

Fees and costs

Displays the fund's ongoing costs as a percentage of assets per year: the PDS management fees and costs, performance fee and transaction costs that make up the total cost ratio (the RG 97 forward estimate, and what was charged last financial year), and the buy / sell spread, sourced from Morningstar.
Management fees and costs
0.29% p.a.
PDS dated
19 DEC 2025

Distributions

Displays the most recent distribution paid per unit and its key dates, sourced from Morningstar.
Latest distribution
0.0003
Ex Date
23 MAR 2026
Record Date
23 MAR 2026
Pay Date
27 MAR 2026
NAV at ex date
40.09
Paid this year
0.0003

Distributions by year

Displays the total distributions paid per unit in each calendar year, sourced from Morningstar.

2024

0.0

2023

0.1

2022

0.0

2017

0.0

2015

0.0

Year Per unit ($)
2024 0.0188
2023 0.1201
2022 0.0045
2017 0.0017
2015 0.0065

Distribution history

Displays the most recent distributions by ex date, sourced from Morningstar.
Ex Date Per unit ($)
23 MAR 2026 0.0003
22 SEP 2025 0.0026
23 JUN 2025 0.0020
24 MAR 2025 0.0142
23 DEC 2024 0.0180
24 JUN 2024 0.0659
18 MAR 2024 0.0361
18 DEC 2023 0.0045
24 SEP 2018 0.0017
16 DEC 2016 0.0065
24 DEC 2014 0.4802
19 DEC 2014 0.0092

Sustainability rating · 31 AUG 2026

Displays the Morningstar Sustainability Rating (1 to 5 globes, more is better) and the portfolio ESG risk score behind it (lower is less risk), against the average of the fund's global category, sourced from Morningstar and Sustainalytics.

Below Average

ESG risk score

27.52

Negligible Low Medium High Severe

Category average 21.96

Rank in category
86th percentile of 594 funds
Environmental risk
0.67
Social risk
2.80
Governance risk
1.04
Portfolio covered
94.2%

ESG risk of holdings

Displays the share of the covered portfolio held in companies with negligible, low, medium, high and severe ESG risk, sourced from Morningstar and Sustainalytics.
Negligible
0.00%
Low
7.91%
Medium
52.97%
High
39.12%
Severe
0.00%

0.00% of assets are in companies with high or severe controversies.

Carbon · 31 AUG 2026

Displays the portfolio carbon risk score (lower is less exposure to the transition to a low-carbon economy), the share of the portfolio in companies with fossil fuel revenue, and whether the fund earns Morningstar's Low Carbon Designation, sourced from Morningstar and Sustainalytics.

Carbon risk score

4.69

Low Medium High Severe

Category average 2.74

Carbon risk
Low Risk
Rank in category
78th percentile of 313 funds
Fossil fuel involvement
0.00%
Category average
0.16%
Low Carbon Designation
Yes
Portfolio covered
94.2%

Fund managers

Displays the people Morningstar lists as managers of the fund, sourced from Morningstar.
  • Peter Hubbard
  • Michael Jeanette
  • Pratik Doshi

Tenure

Displays how long the managers have run the fund: the average and longest tenure, who has served longest, the latest appointment and how many other funds the team manages, sourced from Morningstar.
Number of managers
3
Average tenure
13.3 years
Longest tenure
16.5 years
Longest serving
Peter Hubbard, Michael Jeanette · since 7 APR 2010
Most recent appointment
Pratik Doshi · since 20 DEC 2019
Managed since
7 APR 2010
Other funds managed
292
Displays all company announcements released by the company to the exchange, sourced from Morningstar.

Announcements

Announcements are available for ASX-listed companies only.

Opinion

No opinions for this company yet.

Action

No actions for this company yet.

image description

Relevant suggested news and content from the site

Back to top